Results 301 to 310 of about 1,940,460 (362)

Integrating network pharmacology and experimental validation to explore the mechanism of Yiqi Ziyin in treating immune thrombocytopenia. [PDF]

Sci Rep
Wang J, Wang B, Zhang Y, Wu LQ.
europepmc   +1 more source

Efficacy and Thrombotic Risk of Thrombopoietin Receptor Agonists for Immune Thrombocytopenia Secondary to Systemic Lupus and Antiphospholipid Syndrome: French Experience With 80 Patients

American Journal of Hematology, Volume 100, Issue 11, Page 1972-1982, November 2025.
ABSTRACT Only few data are available regarding the efficacy and safety of thrombopoietin receptor agonists (TPO‐RAs) for treating systemic lupus erythematosus (SLE) and/or antiphospholipid syndrome (APS)‐associated immune thrombocytopenia (ITP). We retrospectively assessed the efficacy and safety of TPO‐RAs in 80 adults with ITP in three subgroups: (1)
Cindy Marques, Guillaume Moulis, Mickaël Roussotte, Bernard Bonnotte, Jean‐François Viallard, Julie Graveleau, Hervé Lobbes, Nathalie Costedoat‐Chalumeau, Alban Deroux, Delphine Gobert, Antoine Dossier, Laurent Gilardin, Olivier Lambotte, Mylène Dufrenoy, Matthieu Mahévas, Marc Michel, Pascal Sève, Bertrand Godeau   +17 more
wiley   +1 more source

Late-onset immune thrombocytopenia after unrelated cord blood transplantation for chronic myelomonocytic leukemia. [PDF]

Blood Cell Ther
Arai S, Matsumoto K, Tashiro H, Kato S, Konuma T, Ooi J.   +5 more
europepmc   +1 more source

Comorbidities in Mild WAS/XLT Require Lifelong Follow‐Up and Consideration of Definitive Treatment

American Journal of Hematology, Volume 100, Issue 11, Page 2004-2016, November 2025.
Our study followed the clinical and biological course of 261 WAS/XLT patients, including 170 with a mild form of the disease. The occurrence of late complications even in mild patients confirms the importance of offering lifelong follow‐up and considering definitive treatment (HSCT/gene therapy) for all patients.
Coralie Mallebranche, Charline Miot, Mickael Alligon, Despina Moshous, Benedicte Neven, Vincent Barlogis, Virginie Courteille, Bénédicte Bruno, Marie Ouachée‐Chardin, Dalila Adjaoud, Yves Delneste, Olivier Bouaziz, Capucine Picard, Alain Fischer, Nizar Mahlaoui, Isabelle Pellier, Members of the CEREDIH French PID Study Group   +16 more
wiley   +1 more source

The role of genetic sequencing in the diagnostic workup for chronic immune thrombocytopenia. [PDF]

Blood Adv
Joshi N, Lango-Allen H, Downes K, Simeoni I, Vladescu C, Paul D, Hart A, Ademokun C, Cooper N.   +8 more
europepmc   +1 more source

Recursive Partitioning to Differentiate Acquired From Inherited Bone Marrow Failure Syndromes

American Journal of Hematology, Volume 100, Issue 11, Page 1983-1992, November 2025.
ABSTRACT Distinguishing inherited bone marrow failure (IBMF) from acquired aplastic anemia (aAA) at diagnosis is a major clinical challenge and is essential for appropriate treatment and patients' counseling. Genetic testing to exclude IBMF is frequently subject to delays of several months and may not be available in all centers and could not be ...
Eléonore Kaphan, Anouk Walter‐Petrich, Lise Larcher, Thierry Leblanc, Benedicte Bruno, Edouard Forcade, Cecile Renard, Arthur Sterin, Michael Loschi, Elodie Lainey, Jean Soulier, Caroline Kannengiesser, Gérard Socié, Régis Peffault de Latour, Mony Fahd, Jérome Lambert, Flore Sicre De Fontbrune   +16 more
wiley   +1 more source

Safe and Efficacious Use of Low-Dose Rituximab in Postpubertal Paediatric Patients With Immune Thrombocytopenia. [PDF]

EJHaem
Darlow J, Gurumurthy G, Jeffreys N, Reynolds L, Deshani V, Grainger J.   +5 more
europepmc   +1 more source

Routine Monitoring of CAR‐T‐Cells Expansion and Persistence in Patients With Aggressive Large B‐Cell Lymphoma by Flow Cytometry: A Single‐Center Experience

Hematological Oncology, Volume 43, Issue 6, November 2025.
ABSTRACT This retrospective, single‐center study evaluated routine flow cytometry (FC) monitoring of CAR‐T‐cells in 45 patients with aggressive large B‐cell lymphoma (LBCL). CAR‐T‐cells expansion was assessed from Day 0 to Month 12. Peak expansion occurred on Day 7 after axi‐cel (median 39.3% of total lymphocytes; 87 cells/mm3) and Day 10 for tisa‐cel (
Alexandra Zduniak, Jérémie Martinet, Emilie Lévêque, Stéphanie Becker, David Tonnelet, Elodie Dos Santos, Claire Leroy, Mustafa Alani, Jean Rouvet, Marine Brousseau, Camille Giverne, Alexis Cuffel, Serge Jacquot, Arnaud Roucheux, Alice Veuiller, Nicolas Lecornu, Misa Eugene Norbert, Olivier Boyer, Hervé Tilly, Fabrice Jardin, Jean‐Baptiste Latouche, Vincent Camus   +21 more
wiley   +1 more source

Letter regarding "Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia". [PDF]

J Vet Intern Med
Wun MK.
europepmc   +1 more source

Review of the Management of Relapsed/Refractory Follicular Lymphoma: An Italian Perspective

Hematological Oncology, Volume 43, Issue 6, November 2025.
ABSTRACT Follicular lymphoma (FL) is an indolent disease characterized by multiple relapses and eventual refractoriness to therapy. Despite advancements in therapeutic approaches, FL treatment algorithm and management remain not well‐established, necessitating both ongoing research into novel therapeutic strategies and in stating patient journey.
Giacomo Loseto, Maria Chiara Tisi, Antonella Anastasia, Alessandro Broccoli, Ilaria Del Giudice, Caterina Patti, Benedetta Puccini, Caterina Stelitano, Vittorio Zilioli, Stefano Luminari   +9 more
wiley   +1 more source